ACADIA Pharmaceuticals Reports Second Quarter 2018 Financial Results
Go back to ACADIA Pharmaceuticals Reports Second Quarter 2018 Financial Results| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 27.29 -0.16 (0.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.45 | 52 Week High | $42.49 | |||
| Open | $27.37 | 52 Week Low | $16.64 | |||
| Day High | $27.48 | P/E | N/A | |||
| Day Low | $26.73 | EPS | $-0.42 | |||
| Volume | 5,482,817 | |||||
| NEWMARKET CORPORATION (NYSE: NEU) | Delayed: 891.87 +2.68 (0.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $889.19 | 52 Week High | $447.97 | |||
| Open | $915.07 | 52 Week Low | $322.54 | |||
| Day High | $915.07 | P/E | 48.98 | |||
| Day Low | $881.89 | EPS | $18.21 | |||
| Volume | 200,590 | |||||
